PMVP
PMV Pharmaceuticals Inc
Price:  
1.26 
USD
Volume:  
82,407.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

PMVP WACC - Weighted Average Cost of Capital

The WACC of PMV Pharmaceuticals Inc (PMVP) is 9.8%.

The Cost of Equity of PMV Pharmaceuticals Inc (PMVP) is 14.65%.
The Cost of Debt of PMV Pharmaceuticals Inc (PMVP) is 5.00%.

Range Selected
Cost of equity 12.30% - 17.00% 14.65%
Tax rate -% - -% -%
Cost of debt 5.00% - 5.00% 5.00%
WACC 8.7% - 11.0% 9.8%
WACC

PMVP WACC calculation

Category Low High
Long-term bond rate 3.9% 4.4%
Equity market risk premium 4.6% 5.6%
Adjusted beta 1.84 2.17
Additional risk adjustments 0.0% 0.5%
Cost of equity 12.30% 17.00%
Tax rate -% -%
Debt/Equity ratio 1 1
Cost of debt 5.00% 5.00%
After-tax WACC 8.7% 11.0%
Selected WACC 9.8%